These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7128728)

  • 1. Glutamate oxaloacetate transaminase (GOT) in the dy2J genotypes of C57BL/6J mice: possible involvement of regulatory defect in muscular dystrophy.
    Singh SM; Phillips A; Wang CH
    Experientia; 1982 Aug; 38(8):917-8. PubMed ID: 7128728
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of homozygous and heterozygous dy2J mice by PCR.
    Vilquin JT; Vignier N; Tremblay JP; Engvall E; Schwartz K; Fiszman M
    Neuromuscul Disord; 2000 Jan; 10(1):59-62. PubMed ID: 10677866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophic mutation (dy2J) affecting regulation of lactate dehydrogenase (LDH) and pyruvate kinase (PK) in C57BL/6J mice.
    Singh SM; Wang CH; Phillips A
    Experientia; 1982 Dec; 38(12):1487-9. PubMed ID: 7151975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate oxalate transaminase (GOT) genetics in Mus musculus: linkage, polymorphism, and phenotypes of the Got-2 and Got-1 loci.
    DeLorenzo RJ; Ruddle FH
    Biochem Genet; 1970 Apr; 4(2):259-73. PubMed ID: 4193185
    [No Abstract]   [Full Text] [Related]  

  • 5. Histochemical and morphological study of dystrophic (C57BL/6J dy2j/dy2j) and normal muscle.
    Dribin LB; Simpson SB
    Exp Neurol; 1977 Sep; 56(3):480-97. PubMed ID: 142018
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of dy and dy2J, two alleles expressing forms of muscular dystrophy in the mouse.
    Macpike AD; Meier H
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):670-2. PubMed ID: 1265049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood plasma pyruvate kinase as a marker of muscular dystrophy. Properties in dystrophic chickens and hamsters.
    Liu PK; Barnard EA; Barnard PJ
    Exp Neurol; 1980 Mar; 67(3):581-600. PubMed ID: 7353617
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracellular localization of glutamic oxaloacetic transaminase isozymes.
    Wada H; Sakakibara R; Kamisaki Y; Horio Y
    Prog Clin Biol Res; 1984; 144B():33-42. PubMed ID: 6718415
    [No Abstract]   [Full Text] [Related]  

  • 9. Level of the nerve growth factor activity in the submaxillary glands of genetically dystrophic mouse (C57BL/6J).
    Furukawa S; Nishitani H; Hayashi K
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1202-6. PubMed ID: 901471
    [No Abstract]   [Full Text] [Related]  

  • 10. Histochemical and structural analyses of the phenotypic expression of the dystrophic gene in the 129/ReJ dy/dy and the C57BL/6J dy2J/dy2J mice.
    Butler J; Cosmos E
    Exp Neurol; 1977 Dec; 57(3):666-81. PubMed ID: 923672
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrastructure of muscle spindles in C57BL/6J dy2J/dy2J dystrophic mice.
    James NT; Meek GA
    Experientia; 1979 Jan; 35(1):108-9. PubMed ID: 154410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control and intracellular localization of glutamate oxaloacetic transaminase in maize.
    Scandalios JG; Sorenson JC; Ott LA
    Biochem Genet; 1975 Dec; 13(11-12):759-69. PubMed ID: 1200976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzyme determination in liver and muscle of mice with hereditary muscular dystrophy].
    Harm K
    Enzymol Biol Clin (Basel); 1968; 9(3):205-18. PubMed ID: 5313882
    [No Abstract]   [Full Text] [Related]  

  • 14. Capacity of foetal spinal cord obtained from dystrophic mice (dy2J) to promote muscle regeneration.
    Hamburgh M; Peterson E; Bornstein MB; Kirk C
    Nature; 1975 Jul; 256(5514):219-20. PubMed ID: 1171376
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD.
    Moreira Soares Oliveira B; Durbeej M; Holmberg J
    PLoS One; 2017; 12(8):e0181950. PubMed ID: 28771630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping studies on human mitochondrial glutamate oxaloacetate transaminase.
    Jeremiah SJ; Povey S; Burley MW; Kielty C; Lee M; Spowart G; Corney G; Cook PJ
    Ann Hum Genet; 1982 May; 46(2):145-52. PubMed ID: 7114792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased parvalbumin contents in skeletal muscles of C57BL/6J(dy2J/dy2J) dystrophic mice.
    Klug G; Reichmann H; Pette D
    Muscle Nerve; 1985 Sep; 8(7):576-9. PubMed ID: 4047089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiology of the neuromuscular junction of the laminin-2 (merosin) deficient C57 BL/6J dy2J/dy2J dystrophic mouse.
    Edwards JP; Hatton PA; Wareham AC
    Brain Res; 1998 Mar; 788(1-2):262-8. PubMed ID: 9555049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new subline of mice with the mutant gene dystrophia muscularis.
    Zdorovskaya EP; Lotosh EA; Neifakh SA
    Sov Genet; 1974 Oct; 8(11):1379-85. PubMed ID: 4445900
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on gluconeogenic mitochondrial enzymes. II. The conversion of glutamate to alpha-ketoglutarate by bovine liver mitochondrial glutamate dehydrogenase and glutamate-oxaloacetate transaminase.
    Fahien LA; Strmecki M
    Arch Biochem Biophys; 1969 Mar; 130(1):456-67. PubMed ID: 4305164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.